Asia

The conference shed light on varied areas pertaining to reproductive medicine as it explored potential treatment and solutions for Assisted Reproductive Technologies
The First Polyethylene Glycol Preparation for Chronic Constipation in Japan
Biotechs and pharmas strengthened their leadership teams with these appointments. Find news from Mersana, Foamix, Allergan, and more.
Francis Collins, director of the National Institutes of Health (NIH) and the scientist who led the Human Genome Project, weighed in on the recent case of He Jiankui.
As part of its commitment to corporate social responsibility, Elaf Group has organized a breast cancer awareness campaign, featuring an educational seminar which encourages its women employees to undergo screening for the early detection of breast cancer and significantly increase the chances of treating the disease.
As Monotherapy for Partial-Onset Seizures Aiming for Submission in Jap
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. Although most readers will already be aware of it, the biggest story, perhaps the biggest story of the year—certainly the most controversial—involves a Chinese researcher who used CRISPR to modify embryos to be resistant to HIV, and the recent birth of a set of twins.
He’s research has not been published in a peer-reviewed scientific journal yet. He made his announcement at the Second International Summit on Human Genome Editing earlier this week. The details of the research were met with widespread condemnation and criticism by researchers globally.
FDA
The FDA approved Xospata for adult AML patients who have a FLT3 mutation as detected by an FDA-approved test. Of the 19,000 people in the United States who are estimated to be diagnosed with AML this year, nearly 40 percent will have a FLT3 mutation.
There has been another recall for blood pressure medications. This time Teva Pharmaceutical has issued a voluntary recall for combination forms of its blood pressure drug Amlodipine due to cancer-causing impurities discovered in the tablets.
PRESS RELEASES